AFP and hepatocellular carcinoma: HCC is highly heterogeneous, and commonly used indicators such as α-fetoprotein (AFP), D-γ-hydroxyprothrombin (DCP), and cytokeratin (CK)-18 are unable to meet the clinical prognosis evaluation needs of patients with HCC.